Stegemann S - Search Results

1

Patients' appropriateness, acceptability, usability and preferences for pharmaceutical preparations: Results from a literature review on clinical evidence.

Drumond N, van Riet-Nales DA, Karapinar-Çarkit F, Stegemann S. Drumond N, et al. Among authors: stegemann s. Int J Pharm. 2017 Apr 15;521(1-2):294-305. doi: 10.1016/j.ijpharm.2017.02.029. Epub 2017 Feb 14. Int J Pharm. 2017. PMID: 28229945 Review.

2

Improved therapeutic entities derived from known generics as an unexplored source of innovative drug products.

Stegemann S, Klebovich I, Antal I, Blume HH, Magyar K, Németh G, Paál TL, Stumptner W, Thaler G, Van de Putte A, Shah VP. Stegemann S, et al. Eur J Pharm Sci. 2011 Nov 20;44(4):447-54. doi: 10.1016/j.ejps.2011.09.012. Epub 2011 Sep 24. Eur J Pharm Sci. 2011. PMID: 21968337 Review.

3

Swallowing dysfunction and dysphagia is an unrecognized challenge for oral drug therapy.

Stegemann S, Gosch M, Breitkreutz J. Stegemann S, et al. Int J Pharm. 2012 Jul 1;430(1-2):197-206. doi: 10.1016/j.ijpharm.2012.04.022. Epub 2012 Apr 15. Int J Pharm. 2012. PMID: 22525080 Review.

4

Design of pharmaceutical products to meet future patient needs requires modification of current development paradigms and business models.

Stegemann S, Baeyens JP, Becker R, Maio M, Bresciani M, Shreeves T, Ecker F, Gogol M. Stegemann S, et al. Z Gerontol Geriatr. 2014 Jun;47(4):285-7. doi: 10.1007/s00391-014-0647-4. Z Gerontol Geriatr. 2014. PMID: 24740531 Review.

5

Results from a preliminary review of scientific evidence for appropriateness of preparations, dosage forms and other product design elements for older adult patients.

Messina R, Becker R, van Riet-Nales DA, Stegemann S. Messina R, et al. Among authors: stegemann s. Int J Pharm. 2015 Jan 30;478(2):822-8. doi: 10.1016/j.ijpharm.2014.10.052. Epub 2014 Oct 24. Int J Pharm. 2015. PMID: 25445516 Review.

6

Towards better understanding of patient centric drug product development in an increasingly older patient population.

Stegemann S. Stegemann S. Int J Pharm. 2016 Oct 30;512(2):334-342. doi: 10.1016/j.ijpharm.2016.01.051. Epub 2016 Jan 22. Int J Pharm. 2016. PMID: 26807529 Review.

7

Defining Patient Centric Pharmaceutical Drug Product Design.

Stegemann S, Ternik RL, Onder G, Khan MA, van Riet-Nales DA. Stegemann S, et al. AAPS J. 2016 Sep;18(5):1047-1055. doi: 10.1208/s12248-016-9938-6. Epub 2016 Jun 17. AAPS J. 2016. PMID: 27317470 Review.

8

Identification of different shapes, colors and sizes of standard oral dosage forms in diabetes type 2 patients-A pilot study.

Stegemann S, Riedl R, Sourij H. Stegemann S, et al. Int J Pharm. 2017 Jan 30;517(1-2):112-118. doi: 10.1016/j.ijpharm.2016.11.066. Epub 2016 Dec 2. Int J Pharm. 2017. PMID: 27919699

9

Orodispersible films: Towards drug delivery in special populations.

Scarpa M, Stegemann S, Hsiao WK, Pichler H, Gaisford S, Bresciani M, Paudel A, Orlu M. Scarpa M, et al. Among authors: stegemann s. Int J Pharm. 2017 May 15;523(1):327-335. doi: 10.1016/j.ijpharm.2017.03.018. Epub 2017 Mar 14. Int J Pharm. 2017. PMID: 28302515 Free article. Review.

10

Polymer adhesion predictions for oral dosage forms to enhance drug administration safety. Part 1: In vitro approach using particle interaction methods.

Drumond N, Stegemann S. Drumond N, et al. Among authors: stegemann s. Colloids Surf B Biointerfaces. 2018 May 1;165:9-17. doi: 10.1016/j.colsurfb.2018.02.012. Epub 2018 Feb 9. Colloids Surf B Biointerfaces. 2018. PMID: 29448218

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

67 results

Search Page

Filters